Complaints of vertigo and dizziness are frequently encountered in childhood and may coexist with migraine-associated features. The present study reassessed a historical pediatric cohort within an expanded phenotypic framework.
✦ The floor
Discussion
Signed responses from readers of the wire.
Audiologists and clinicians evaluating children with recurrent unexplained vertigo should screen for migraine-associated features, as cases may represent a developmental vestibular migraine spectrum rather than isolated vestibular dysfunction.
Reframing childhood recurrent vertigo within a vestibular migraine spectrum could reduce diagnostic delay and improve management pathways for a historically under-recognized pediatric condition.
- 01Historical pediatric cohort with recurrent unexplained vertigo was re-evaluated using modern diagnostic criteria.
- 02Clinical findings supported reclassifying cases within a developmental vestibular migraine spectrum.
- 03Migraine-associated features (e.g., family history, headache, photophobia) were prominent in the cohort.
- 04Findings suggest childhood recurrent vertigo and vestibular migraine may share a common developmental pathway.
- 05Retrospective cohort design limits causal conclusions but provides a useful clinical hypothesis.
Recurrent vertigo of childhood may represent a developmental vestibular migraine spectrum rather than a distinct clinical entity.
studypartially supportedMigraine-associated clinical features are present in children with recurrent vertigo, supporting a shared pathophysiology.
studypartially supported- PMID
- 42930347
- DOI
- 10.3390/audiolres16050149.
- Journal
- Audiology Research
- Publication type
- research_article
- Evidence level
- 4
- Population
- Pediatric patients with a historical diagnosis of recurrent vertigo of childhood
- Intervention
- Retrospective clinical reassessment using developmental vestibular migraine spectrum criteria
Primary outcomes
Classification of recurrent childhood vertigo within a vestibular migraine spectrum; Prevalence of migraine-associated clinical features in the cohort